Do peptides really get 'everything available to your muscles'?
Quick answer
Some peptides, particularly BPC-157 and GHK-Cu, have demonstrated angiogenic and tissue repair properties in preclinical studies, but human clinical data supporting direct performance enhancement through increased muscular oxygen delivery remains limited and compound-specific. The creator's claim that peptides 'naturally increase oxygen and blood to muscles' conflates distinct physiological mechanisms across very different peptide classes without naming a specific compound or citing any evidence. Patients interested in peptide therapy for recovery or performance should discuss specific compounds, compounding pharmacy standards, and current regulatory status with a licensed provider before use.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @steveapproved actually say?
The transcript is rough, but the core claim is clear enough: whatever @steveapproved is promoting "naturally increases the amount of oxygen and blood that you can get to your muscles" so you can "lift heavier weight" and "get stronger." He positions this as a path to "peak performance" tied to moving 170 pounds. The product category here is peptides.
To be fair, the transcript is garbled in places, likely a transcription artifact. But the sales pitch reads like a classic vasodilation and oxygen-delivery claim, which is a specific physiological assertion that deserves scrutiny. Vague language like "naturally" does a lot of heavy lifting when the mechanism being implied isn't actually spelled out.
Does the science back this up?
Some peptides do have documented effects on blood flow and tissue oxygenation, but the evidence base is nowhere near as clean as this video implies. It depends entirely on which peptide is being discussed, and the creator never names one.
BPC-157, one of the more studied peptides in this category, has shown angiogenic effects in animal models, meaning it may promote the formation of new blood vessels. Sikiric et al. (2018, Current Pharmaceutical Design) documented this in rodent studies. The problem is that robust human clinical trials are largely absent. GHK-Cu has shown some evidence of upregulating genes involved in tissue repair and circulation in vitro (Pickart & Margolina, 2018, Symmetry), but again, human performance data is thin. CJC-1295 and ipamorelin work through growth hormone release, which has downstream effects on recovery, not direct oxygen delivery to muscles during exercise. Conflating these mechanisms is sloppy at best.
What did they get wrong (or right)?
The directional intuition, that some peptides can influence blood flow and recovery, is not completely baseless. That is worth acknowledging. But @steveapproved gets several things wrong in how he frames it.
- Calling this "natural" is misleading. Peptides used for performance are synthetic compounds, often compounded in specialized pharmacies. They are not naturally occurring supplements in any practical sense of how consumers hear that word.
- The claim that peptides directly increase "oxygen to muscles" during performance conflates very different mechanisms. Increased angiogenesis over weeks of healing is not the same as acute oxygen delivery during a lift.
- There is no named peptide, no mechanism explained, and no citation. That is not a minor omission when you are making a physiological performance claim to 8,200 viewers.
- Lifting 170 pounds as proof of efficacy is anecdotal. Without a baseline, a control condition, or any context about the person's training history, this is not evidence of anything.
What should you actually know?
Peptide therapy is a legitimate area of clinical research, and some compounds show real promise. But the gap between animal model data and real-world human performance claims is significant, and creators who paper over that gap with phrases like "naturally increases oxygen" are doing their audience a disservice.
If you are considering peptide therapy for recovery or performance, these are the actual questions worth asking a licensed clinician: Which specific peptide? What is the evidence base for that peptide in humans, not just rodents? Is it legally compounded by an FDA-registered facility? What are the known side effects and monitoring requirements?
The FDA has not approved any of the peptides commonly marketed for performance enhancement for that specific use. Compounded peptides exist in a regulatory gray zone. That does not make them dangerous by default, but it does mean the burden of evidence falls on the person making the claim, not on you to simply trust the TikTok.
Bottom line on this video
@steveapproved is making a broad vascular-performance claim for an unnamed peptide with no cited mechanism, no clinical data, and anecdotal lifting footage as proof. The underlying science on some peptides and blood flow is real but preliminary and highly compound-specific. This video does not give viewers the information they would need to evaluate that science. It gives them a sales pitch dressed up as a discovery.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Do peptides really get 'everything available to your muscles'?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Do peptides really get 'everything available to your muscles'? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Some peptides, particularly BPC-157 and GHK-Cu, have demonstrated angiogenic and tissue repair properties in preclinical studies, but human clinical data supporting direct performance enhancement through increased muscular oxygen delivery remains limited and compound-specific.
FormBlends verdict
Some peptides, particularly BPC-157 and GHK-Cu, have demonstrated angiogenic and tissue repair properties in preclinical studies, but human clinical data supporting direct performance enhancement through increased muscular oxygen delivery remains limited and compound-specific. The creator's claim that peptides 'naturally increase oxygen and blood to muscles' conflates distinct physiological mechanisms across very different peptide classes without naming a specific compound or citing any evidence. Patients interested in peptide therapy for recovery or performance should discuss specific compounds, compounding pharmacy standards, and current regulatory status with a licensed provider before use.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Some peptides, particularly BPC-157 and GHK-Cu, have demonstrated angiogenic and tissue repair properties in preclinical studies, but human clinical data supporting direct performance enhancement through increased muscular oxygen delivery remains limited and compound-specific. The creator's claim that peptides 'naturally increase oxygen and blood to muscles' conflates distinct physiological mechanisms across very different peptide classes without naming a specific compound or citing any evidence. Patients interested in peptide therapy for recovery or performance should discuss specific compounds, compounding pharmacy standards, and current regulatory status with a licensed provider before use.
- BPC-157 has shown angiogenic effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but controlled human trials on performance are largely absent as of 2024.
- Compounded peptides are not FDA-approved for performance enhancement and exist in a regulatory gray zone; this does not make them inherently unsafe, but it does mean efficacy claims require a higher standard of evidence than a TikTok video provides.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- BPC-157 has shown angiogenic effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but controlled human trials on performance are largely absent as of 2024.
- Compounded peptides are not FDA-approved for performance enhancement and exist in a regulatory gray zone; this does not make them inherently unsafe, but it does mean efficacy claims require a higher standard of evidence than a TikTok video provides.
- CJC-1295 and ipamorelin stimulate growth hormone release and may support recovery indirectly, but this mechanism is not the same as directly increasing oxygen delivery to muscles during exercise.
- The word 'natural' applied to synthetic compounded peptides is a red flag in health marketing; these are pharmaceutical-grade compounds, not dietary supplements or endogenous substances in the way that term implies.
- Animal model data on peptides like GHK-Cu shows tissue repair and circulation effects (Pickart & Margolina, 2018, Symmetry), but extrapolating rodent findings to human athletic performance requires clinical validation that has not yet occurred.
- Anecdotal lifting footage without a baseline or control condition is not evidence of efficacy for any intervention, pharmaceutical or otherwise.
- Anyone considering peptide therapy should consult a licensed provider, confirm the compounding pharmacy holds FDA registration, and ask specifically about human evidence for the compound in question, not general peptide category claims.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Steve · TikTok creator
8.2K views on this video
Peak performance starts with getting everything available to your muscles #performanceenhancement #musclegrowth #strengthtraining
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Steve, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.